Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia-Reference-Cited by-同舟云学术

Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia

Published:2014-04-09 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Grabosch Shannon M¹,Shariff Osman M²,Wulff Judith L³,Helm C. William⁴

Affiliation:

1. Saint Louis University School of Medicine; Saint Louis University Department of Obstetrics and Gynaecology; 1025A Commodore Drive Richmond Heights Missouri USA 63117

2. University of Louisville School of Medicine; 3646 Warner Ave Louisville Kentucky USA 40207

3. University of Louisville; Kornhauser Health Sciences Library; 500 South Preston Street Louisville KY USA 40202

4. Queen Elizabeth Hospital; Northern Gynaecological Oncology Centre; Sheriff Hill Gateshead Tyne and Wear UK NE9 6SX

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD004121.pub3/fullpdf

Reference67 articles.

1. A randomized double-blind placebo-controlled phase II trial of the cyclooxygenase-2 inhibitor Celecoxib in the treatment of cervical neoplasia;Farley;Gynecologic Oncology,2006

2. The cyclooxygenase-2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II-III. A phase II trial;Hefler;European Journal of Obstetrics and Gynecology and Reproductive Biology,2005

3. Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study;Ferrandina;Clinical Cancer Research,2003

4. A prospective phase I-II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment;Herrera;International Journal of Radiation Oncology, Biology and Physics,2006

5. Chemoprevention trials and surrogate end point biomarkers in the cervix;Mitchell;Cancer,1995

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Cyclooxigenase-2 Inhibitor Parecoxib Prevents Epidermal Dysplasia in HPV16-Transgenic Mice: Efficacy and Safety Observations;International Journal of Molecular Sciences;2019-08-10

2. Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature;Pharmaceuticals;2018-10-11

3. Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review;Oral Oncology;2018-10

4. New Insights in the Pathogenesis of HPV Infection and the Associated Carcinogenic Processes: The Role of Chronic Inflammation and Oxidative Stress;Journal of Immunology Research;2018-08-27

5. Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia;Cochrane Database of Systematic Reviews;2018-02-12